Spatio-temporal regulation of the balance between cell renewal and cell differentiation is of vital importance for embryonic development and adult homeostasis. Fibroblast growth factor signaling relayed from the mesenchyme to the epithelium is necessary for progenitor maintenance during organogenesis of most endoderm-derived organs, but it is still ambiguous whether the signal is exclusively mitogenic. Furthermore, the downstream mechanisms are largely unknown. In order to elucidate these questions we performed a complementary analysis of fibroblast growth factor 10 (Fg f10), gain-of-function and loss-of-function in the embryonic mouse duodenum, where the progenitor niche is clearly defined and differentiation proceeds in a spatially organized manner. In agreement with a role in progenitor maintenance, FGF10 is expressed in the duodenal mesenchyme during early development while the cognate receptor FGFR2b is expressed in the epithelial progenitor niche. Fg f10 gain-of-function in the epithelium leads to spatial expansion of the progenitor niche and repression of cell differentiation, while loss-of-function results in premature cell differentiation and subsequent epithelial hypoplasia. We conclude that FGF10 mediated mesenchymal-toepithelial signaling maintains the progenitor niche in the embryonic duodenum primarily by repressing cell differentiation, rather than through mitogenic signaling. Furthermore, we demonstrate that FGF10-signaling targets include ETS-family transcription factors, which have previously been shown to regulate epithelial maturation and tumor progression.
Introduction
Organogenesis is a fascinating developmental process involving a series of integrated events leading to the fully functional organ. Expansion of the committed progenitor cell population is an early event in organogenesis. This phase has received increasing attention during the past few years, due to the promising prospect of stem cell therapy, which has led to a need for knowledge on how to expand progenitor cells as a source for replacement therapy for multiple diseases. Likewise, balancing of progenitor cell expansion and differentiation features prominently in adult homeostasis of renewable organs, such as the intestine, and in the mutated state, also during cancer progression.
It is well known that reciprocal signaling between the epithelium and the surrounding mesenchyme via soluble and/or membranetethered signals is necessary for regulating growth and differentiation of the gut epithelium Kedinger et al., 1987) , and several signaling pathways, including WNT (Korinek et al., 1998; Pinto et al., 2003) , BMP (He et al., 2004) , Notch (Fre et al., 2005; Jensen et al., 2000; van Es et al., 2005; Wong et al., 2004) , and Hedgehog (Madison et al., 2005; Ramalho-Santos et al., 2000) have been implicated in regulating gastric and enteric development. Members of the fibroblast growth factor (FGF) family are mediators of mesenchymal-toepithelial signaling in several organs, and are included as a component in many stem cell differentiation protocols. FGF10 in particular, has been shown to be necessary for progenitor maintenance during organogenesis of endoderm-derived organs, but it is still ambiguous whether the signal is exclusively mitogenic, or whether it also regulates cell differentiation. Furthermore, the downstream mechanisms are largely unknown.
Fg f10 is expressed in the mesenchyme of the embryonic duodenum (Bhushan et al., 2001; Kanard et al., 2005; Nyeng et al., 2007) , as well as in the mesenchyme of the lung, stomach, pancreas, colon, and cecum (Bellusci et al., 1997; Burns et al., 2004; Fairbanks et al., 2004; Nyeng et al., 2007; Sala et al., 2006) . Loss-of-function mutation of Fgf10 or its cognate receptor Fg fr2b results in lung agenesis (Arman et al., 1999; Sekine et al., 1999) , and severely affects the development of the glandular stomach (Spencer-Dene et al., 2006) and the pancreas (Bhushan et al., 2001; Pulkkinen et al., 2003) . In the intestines, loss of Fgf10 has been analyzed thoroughly in the colon and the cecum , where attenuated proliferation and increased apoptosis led to colonic atresia and failure of cecal budding. Studies of clinical relevance have implicated Fg f10 in intestinal pathobiology, as Fg f10−/− mice have duodenal and colonic atresia. Unfortunately, the duodenal phenotype was not analyzed further. So far, clinical studies have however failed to identify any association of mutations in Fg f10 and duodenal atresia or anorectal malformations (Kruger et al., 2008; Tatekawa et al., 2007) . The severe phenotype of loss of Fg f10 prompted an analysis of Fg f10 gain-offunction in order to understand the mechanism in more detail. Our studies of the stomach and pancreas have demonstrated that ectopic Fgf10 overexpression in the epithelium results in inhibition of cell differentiation (Norgaard et al., 2003; Nyeng et al., 2007) , a result that was corroborated by Hart et al in the pancreas (Hart et al., 2003) . Quite likely, a central function of FGF-signaling in enteric progenitor maintenance has been overlooked, as previous studies focused mostly on the time after terminal differentiation. We therefore decided to study whether ectopic expression of Fg f10 in the duodenal epithelium, disrupting the endogenous FGF10 gradient emanating from the mesenchyme, would suppress differentiation outside the progenitor niche, leading to an expansion of the niche. Reciprocally, we wished to test whether loss of Fg f10 in the duodenum is sufficient to release progenitor cells and cause premature differentiation.
In the present work, we demonstrate that FGF10 mediated mesenchymal-to-epithelial signaling maintains the progenitor niche in the embryonic small intestine by repressing differentiation. Furthermore, we demonstrate that FGF10-signaling targets in the intestine include ETS-family transcription factors Etv4 and Etv5.
Materials and methods

Mouse derivation
Generation of a pPdx1-Fgf10 FLAG construct and derivation of transgenic mouse (Mus musculus) embryos, as described earlier (Norgaard et al., 2003) , were approved by the UCHSC Animal Care and Use Committee. A total of 3 embryonic day 12.5 (E12.5) and 6 E18.5 pPdx1-Fg f10 FLAG embryos and their wildtype (WT) littermates were obtained by oocyte injection using FVB mice. The day of oocyte transfer was counted as embryonic day 0.5 (E0.5). BrdU (20 mg/kg) was injected 2 h prior to isolation of embryos. Targeted disruption of Fgf10 has already been described (Min et al., 1998) . A total of 8 E14.5 and 8 E18.5 Fgf10−/− embryos were obtained by timed mating of heterozygotes which had been outbred on a CD1 background. The day of vaginal plug was counted as E0.5. Heterozygotic littermates were used as controls throughout, as they were indistinguishable from wildtype embryos.
All embryos were genotyped by PCR. pPdx1-Fg f10 FLAG embryos were genotyped using Fg f10-Flag primers (Table S1 ) and Fgf10−/− embryos were genotyped using Fg f10 KO P1, P2, P3 and P4 primers as described (Sekine et al., 1999) . Expression of the pPdx1-Fg f10 FLAG construct was confirmed by RT-PCR of three E18.5 embryos and WT littermates. pPdx1-Fg f10 FLAG embryos varied somewhat in their expression of the transgene, but although phenotypes were not identical, they were highly similar, and the phenotypic variation never exceeded that observed in Fg f10−/− mice.
Tissue and RNA isolation
Whole guts were dissected in ice-cold PBS and fixed in 4% PFA overnight. They were then immersed in 30% sucrose for at least 4 h, in 1:1 30% sucrose and OCT embedding medium for 1 h and finally in OCT for 1 h before embedding. Tissue blocks were freeze sectioned at a thickness of 6 μm using a cryotome. Embryos for RNA analysis were dissected in ice-cold PBS and the upper half of the duodenum including mesenchyme and epithelium was extracted using the RNeasy (Qiagen) kit including a DNAse treatment step. Endogenous Fgf expression was analyzed using RNA from embryos from time-mated CD1 mice. RNA from E12.5 whole small intestine was pooled from 5 embryos for each sample. Whole duodenal tissue was pooled from 4 E14.5 embryos, 3 E15.5 embryos or 2 embryos for each of the samples at E16.5, E17.5 and E18.5. At least three samples were analyzed per time point.
Multiplex RT-PCR analysis
Purified total RNA was analyzed by a semi-quantitative low-cycle radioactive multiplex RT-PCR (MPX-RT-PCR) method previously described (Jensen et al., 1996) with 2 μg of total RNA per sample. A primer set for the TATA box binding protein (Tbp) or Alpha-tubulin (α-tubulin) was included in all reactions as an internal control and used for standardization. Primers (Supplementary Material Table S1) were specifically designed for MPX-RT-PCR, optimized for exponential amplification within the cycle range and tested for interference. Six primers were included in each reaction and the reaction was carried out at 96°C for 1 min, followed by 28 cycles of 96°C for 30 s, 55°C for 30 s and 73°C for 30 s. Following the RT-PCR reaction, samples were run on a denaturing sequencing gel. The gel was subsequently exposed to phosphoimage storage screen for 3 days, after which the screen was scanned. Experiments were carried out in triplicate for each sample and values are expressed as mean± SEM relative to Tbp or α-tubulin.
Immunohistochemistry
Immunohistochemistry (IHC) was carried out as already described (Norgaard et al., 2003) . Primary antibodies are included in Table S1 . 0.1% Triton X-100 was added to the blocking buffer. After overnight incubation with the primary antibodies, slides were washed and incubated with rabbit/goat/rat/mouse/guinea pig secondary antibody conjugated to Texas red/Cy2/AMCA (Jackson ImmunoResearch, PA, USA) for 1 h or taken through the Histostain kit protocol (Zymed/ Invitrogen, CA, USA), followed by tyramide signal amplification (TSA) (Perkin Elmer, MA, USA) as indicated in Table S1 . Nuclei were stained with Hoechst dye for morphometric studies. Mature goblet cells were stained for 1 h using rhodamine-conjugated Dolichos biflorus agglutinin (DBA), while immature goblet cells were stained with fluorescein conjugated Bauhinia purpurea lectin/agglutinin (BPA). Apoptotic cells were detected using a TUNEL kit (DeadEnd Fluorometric TUNEL System, Promega, WI, USA) according to protocol.
In situ hybridization
Digoxygenin labeled RNA in situ probes where synthesized and in situ hybridization (ISH) of tissue sections carried out as in (Norgaard et al., 2003) from purified restriction fragments obtained from sequence-validated plasmids listed in Supplementary Material Table S1 .
Histochemistry
Harris hematoxylin and eosin Y staining was carried out according to standard protocols.
Goblet cells were stained for morphometry using Alcian blue/ Periodic Acid Schiff (PAS). Frozen slides were thawed and stained 15 min with Alcian Blue (Newcomersupply, WI, USA). After washing, the slides were covered with periodic acid (Sigma-Aldrich, MO, USA) for 5 min, rinsed and stained with Schiffs reagent for 6 min (Sigma-Aldrich). Finally, slides were washed and nuclei stained with Gills hematoxylin (Sigma-Aldrich).
Image analysis
Images were obtained in ImagePro v. 4.5 (Media Cybernetics, MD, USA) using a Pixera CL600 camera, mounted on an Olympus BX51 microscope station equipped with differential interference contrast.
All analysis was performed on at least three cryosections from each of three E18.5 pPdx1-Fg f10 FLAG and three wildtype littermates or four E18.5/E14.5 Fg f10−/− and four heterozygous littermates for each age. The sections were distributed equally across the duodenum. For morphometric analysis, digital images of a maximum of ten nonoverlapping fields of view were quantified per slide in ImagePro. Total epithelial area was measured using area integration based on Ecadherin immunostaining. The total number of epithelial cells was automatically counted by the software based on Hoechst and Ecadherin staining after application of the limited watershed algorithm. Specialized cell types were counted manually based on immunostaining, with exception of goblet cells which were quantified based on Alcian blue/PAS staining.
Results
Fgf10 and Fgfr2b are expressed complementarily in the duodenal mesenchyme and epithelium
In order to verify that FGF10 and FGFR2b mediate mesenchymalepithelial signaling in the duodenum we first performed an expression analysis of the two isoforms of Fg fr2 as well as the known FGFR2b ligands Fgf1, Fgf3, Fgf7 and Fgf10 in whole duodenum during development. mRNA analysis showed that while expression of Fgf1 increased during development and Fg f3 and Fg f7 levels where negligible, Fgf10 expression was highest at E14.5 before initiation of terminal differentiation (Fig. 1A, B ), in accordance with a role in progenitor maintenance. Both isoforms of Fg fr2 where expressed in the duodenum at a constant level throughout development taking into account the internal control ( Fig. 1B ). We proceeded to analyze the spatial expression pattern of Fg f10 and Fg fr2b in more detail. In situ hybridization (ISH) confirmed that Fgf10 is highly expressed in the stomach and intestine at E14.5 (Fig. 1C) , with strongest expression in the mesenchyme (Fig. 1C') . At E18.5, when Fgf10 levels are lower, expression is mainly confined to smooth muscle ( Fig. 1D ). Using the Bek antibody which detects both splice forms of FGFR2 we observed expression primarily in the epithelium at E14.5 and E18.5. At E18.5, expression was limited to the intervillus epithelium, where the progenitor niche is located ( Fig. 1E, F ). Analysis of Fg fr2b−/− tissue using the Bek antibody confirmed that only FGFR2b is expressed in the intestinal epithelium, while FGFR2c is mesenchymal, as epithelial staining was absent (results not shown). High Fg f10 expression in the Fig. 1 . Fibroblast growth factor expression in the developing duodenum. A: MPX-RT-PCR analysis of Fgf1, Fgf3, Fgf7, and Fgf10 expression in E12.5 small intestine and E14.5-E18.5 duodenum. Dotted line indicates that E12.5 small intestine samples are not directly comparable with duodenum samples. N = 3 per age. Graph depicts band volume intensity as a fraction of Tbp intensity. B: Representative MPX-RT-PCR bands for Fgf10, FgfR2-IIIc, FgfR2-IIIb and Tbp. N = 3 per age. C: ISH of E14.5 embryo (From Genepaint (Visel et al., 2004) ) with Fgf10 probe. C': Magnification of duodenum from C. D: Fgf10 ISH of E18.5 duodenum. E and F: IHC for FGFR2 using an antibody that detects both isoforms. Duodenum from E14.5 (E) and E18.5 (F) with E-cadherin counterstain in F. Mes: mesenchyme, Epi: epithelium. duodenum before terminal differentiation and confinement of Fgfr2b expression to the progenitor niche makes it plausible that FGF10 has a role in duodenal progenitor maintenance, similarly to what has been observed in other endodermal organs.
Fgf10 overexpression interferes with epithelial morphogenesis and disrupts the crypt-villus axis
To test whether Fg f10 overexpression in the epithelium itself can trigger expansion of the duodenal progenitor pool, we analyzed pPdx1-Fgf10 FLAG embryos, which express Fg f10 in the Pdx1 domain (Norgaard et al., 2003; Nyeng et al., 2007) . Pdx1 is expressed in epithelium of the posterior stomach, anterior duodenum and the pancreatic anlagen from their initial specification at E8.5 (Ohlsson et al., 1993) and continues to be expressed in the duodenum throughout development and into adulthood (Boyer et al., 2006; Nyeng et al., 2007) .
In order to verify expression of the transgene, mRNA and protein expression analyses were carried out using low sensitivity assays that do not detect endogenous levels of Fg f10. At E12.5, exogenous Fg f10 mRNA and protein were mosaically expressed in the uniform epithelium (Supplemental Material Fig. S1 ). At E18.5, exogenous Fg f10 mRNA expression was confined to the basal intervillus region, as would be expected based on the Pdx1 expression domain. However, FGF10 protein as detected with FGF10 or FLAG antibodies was also expressed outside the intervillus region at this time, as the basement membrane was conditioned with FGF10/FLAG along the greater part of the villus. We therefore conclude that the transgene is expressed in the basal domain of the duodenum, but that the protein is found along the entire crypt-villus axis, most likely due to secretion and cell membrane adherence.
As pPdx1-Fg f10 FLAG mice die at birth, each embryo was obtained by oocyte injection and represents a separate integration event. As a result transgene expression levels varied somewhat between embryos (Supplemental Material Fig. S1K ), but although not identical, phenotypes were highly similar.
Histological analysis revealed a striking phenotype manifested after terminal differentiation. At E12.5, when the duodenal epithelium normally forms a multilayered cylinder of uniformly PDX1 and FGFR2 expressing cells ( Fig. 2A) , the pPdx1-Fg f10 FLAG epithelium already displayed some defects in morphogenesis. The epithelium was irregular in places, consisting of multilayered as well as monolayered regions of cells with variable PDX1 expression ( Fig. 2B ), but unchanged FGFR2 expression (insert in Fig. 2B ). These changes were not confined to regions with FGF10 FLAG expressing cells. At E18.5, villus morphogenesis was aberrant with pronounced branching (arborization) ( Fig. 2D and H&E staining in Supplementary Material Fig. S2B ). The epithelial cells were however properly polarized on the villi with lateral expression of β-catenin ( Fig. 2C -G). One exception was seen in ectopic branch nodes (arrows in Fig. 2D ), where cells were unpolarized ( Fig. 2H ). These branch nodes were only found in transgenic tissue and were strongly PDX1 positive ( Fig. 2H ), although PDX1 is normally confined to the basal intervillus region ( Fig. 2E and G). FGFR2 expression had also expanded outside the basal region ( Fig. 2I -L) and FgfR2b was upregulated in all embryos analyzed ( Fig. 2Q ), suggesting an expansion of the basal population into the villus domain. In order to confirm an expansion of the basal niche we analyzed expression of the basal markers Cdx2 and . We also analyzed expression of the adult enteric stem cell marker BMI1 (Sangiorgi and Capecchi, 2008) , and found a marked expansion of BMI1 expressing cells from the intervillus region to the entire epithelium ( Fig. 2M -P) We conclude that increased presence of FGF10 in duodenum leads to a complete failure in establishment of a spatially restricted progenitor niche. Since the progenitor niche with proliferating cells is normally already confined to the basal intervillus region at E18.5, we next questioned whether cell cycle control would also be affected by FGF10.
Failure to confine a proliferative niche in the presence of high FGF10 levels does not impact the proliferative index A clear disruption of the proliferative niche was evident at E18.5: Proliferating cells positive for phospho-Histone H3 (pHH3) ( Fig. 3D and E) or BrdU ( Fig. 3F and G) were distributed throughout the villus in the pPdx1-Fgf10 FLAG duodenum as opposed to a strict confinement of proliferating cells to the basal intervillus region in wildtype littermates. Since the proliferative niche is the seat of the progenitor cells, these results provide further evidence that ectopic expression of FGF10 caused expansion of the progenitor niche. Surprisingly, this expansion was not correlated with an increase in proliferative index in the epithelium, as pHH3 positive cells per epithelial area or as a percentage of epithelial cells was unaltered ( Fig. 3A and B ). Mean cell size ( Fig. 3C ) as well as apoptosis rate (data not shown) was also unchanged, precluding that these parameters caused the observed changes. The number of pHH3 positive cells per area was also unchanged in the mesenchyme (pPdx1-Fgf10: 41cells/mm 2 ± 9. WT: 51 cells/mm 2 ±20, p = 0.6). Expansion of the progenitor niche is therefore most likely due to failure of cells to exit the progenitor pool through terminal differentiation.
FGF10 overexpression causes a global attenuation of cell maturation
The intestinal Paneth cells, goblet cells, enteroendocrine cells and absorptive enterocytes derive from a common enteric progenitor. Although the enteric cells are not fully mature until after birth, they can be distinguished prenatally based on cell-specific expression. In situ hybridization for Cryptdin-1 (Defa1) (Desai et al., 2008) and multiplex RT-PCR for Cryptdin-6 (Defa6) demonstrated a complete absence of these cryptdins in E18.5 pPdx1-Fgf10 FLAG duodenum, at a time when wildtype littermates have an abundance of Paneth cell precursors expressing Cryptdin-1 and Cryptdin-6 mRNA (Fig. 4A-B and Supplementary Material Fig. S3A ). Likewise, in situ hybridization and multiplex RT-PCR for Fabp2 revealed that the number of absorptive enterocytes was greatly diminished by the ectopic expression of Fgf10 (Fig. 4C-D and Supplementary Material Fig.  S3B ). Conversely, Trefoil factor 3 (Tff3) mRNA analysis (Fig. 4E-F and Supplementary Material Fig. S3C ) as well as staining with alcian blue or alcian blue/PAS (results not shown) showed that goblet cells were still present in comparable numbers to wildtype. This was confirmed by morphometric analysis of alcian blue/PAS positive cells (Fig. 4J) . However, goblet cells in transgenic mice displayed a significantly lowered reactivity for Dolichos Biflorus Agglutin (DBA, Fig. 4G-H) , which is only present in mature goblet cells (Boland et al., 1982; Wurster et al., 1983) , and instead reacted with Bauhinia Purpurea Agglutinin (BPA). Goblet cells that did bind DBA also bound BPA in most cases (See insert in Fig. 4H ). This was never observed in the WT duodenum. BPA preferentially labels less differentiated mucin in human goblet cells found at the bottom of crypts (Boland et al., 1982) . We confirmed that this is also the case in the mouse (Fig. 4I) , where BPA was confined to crypt cells while DBA was found further up along the radial axis in the colon (see insert in Fig. 4I ). We conclude that goblet cell maturation is arrested at an immature state by Fgf10 overexpression. Enteroendocrine cells, as detected using the pan-endocrine marker Chromogranin A (ChrgA), were reduced by more than half (57% reduction, *p b 0.05, Fig. 5A ). Morphometric analysis for the various enteroendocrine cell types revealed that this overall decrease was due to a marked reduction in secretin producing enterochromaffin cells (40% reduction, *p b 0.05) and somatostatin producing D cells (56% reduction, *p b 0.05). The mean of both the GIP (44% reduction, p = 0.19) and serotonin (48% decrease, p = 0.15) positive cells in pPdx1-Fgf10 FLAG duodenum were not significantly changed, although all transgenic embryos had lower cell numbers than wildtype littermates. We ascribe this to a pronounced litterspecific variation among both wildtype and transgenic embryos (see error bars in Fig. 5A ). The occurrence of CCK and ghrelin producing cells was unchanged, showing that these enteroendocrine cell fates remain irresponsive to FGF10. In conclusion, a global attenuation, but not complete inhibition, of cell differentiation could be ascertained. We therefore asked whether a specific attenuation of early precursor cells was occurring.
Growth factor independent 1 (GFI1) is a zinc finger transcription factor important for regulating Paneth/goblet versus enteroendocrine cell fate (Shroyer et al., 2005) . GFI1 is expressed in the secretory cell progenitor and in endocrine cells (Fig. 5F, G) . Since immature goblet cells still formed while endocrine cell differentiation was attenuated, we tested whether this could be due to direct changes in GFI1. Fewer GFI1 + cells were present in the transgenic epithelium ( Fig. 5H-I) . While GFI1 co-localized with ChrgA in most wildtype cells ( Fig. 5F-G) , the few GFI1 + cells found in the pPdx1-Fgf10 FLAG duodenum were ChrgA negative ( Fig. 5H-I) . Atonal homolog 1 (Atoh1/Math1), which is upstream from GFI-1 and is necessary for differentiation of all enteric secretory cells (Yang et al., 2001) , was also much decreased in pPdx1-Fgf10 FLAG duodenum ( Fig. 5D-E) . Most of the remaining Math1 + cells co-localized with ChrgA ( Fig. 5E ), representing the few endocrine cells that formed. MATH1 single-positive goblet cell precursors were found in very few cases (data not shown), demonstrating that the inhibiting effect of FGF10 is acting on the common secretory precursor cells as well as the absorptive enterocyte cell lineage, but that the few precursor cells that do form, preferentially enter the goblet cell lineage.
Overexpression of FGF10 leads to upregulation of ETS-factors
In order to elucidate the downstream effects of ectopic FGF10 overexpression, we analyzed expression of downstream target of FGFsignaling in three pPdx1-Fgf10 FLAG embryos (designated A, B and C). Sprouty2 (Spry2), a FGF-induced feedback inhibitor (Minowada et al., 1999) , was upregulated in transgenic duodenum (Fig. 6A ) confirming that transgenic Fgf10 activates FGF-signaling. The ETS-factors Etv5 (Erm) and Etv4 (Pea3) are targets of the MAP-kinase pathway and have been shown by our group to mediate FGF10 downstream effects in the pancreas , and probably has a similar function in the lung (Liu et al., 2003) . Etv5 and Etv4 were significantly upregulated in all three embryos compared to littermate controls ( Figs. 6B-C) . IHC for ETV4 further demonstrated that expression was upregulated and that this was due to an expansion of the expression domain from the progenitor niche to the villus epithelium ( Fig. 6D-E) . Fgf10 overexpression thus caused transcriptional upregulation of ETSfactor targets of the MAP-kinase pathway.
We did not find any changes in Wnt and BMP signaling (Supplementary Material Fig. S4 ), and although we did see a transcriptional decrease in the Notch ligand Delta1, we failed to find changes in Notch, Jagged and Hes1 expression (Supplementary Material Fig. S4 and results not shown).
Loss of Fgf10 results in epithelial hypoplasia
Given that gain-of-function of Fgf10 leads to attenuation of cell differentiation and expansion of the progenitor niche, we questioned using a loss-of-function model whether Fgf10 is required for suppression of differentiation in the progenitor population. A preliminary inspection of E14.5 Fgf10−/− embryos revealed minor alterations of the duodenum, which was slightly thinner and in some cases had a bend between anterior and posterior duodenum (Fig. 7A, asterisk) . At E18.5 the duodenum was noticeably smaller and duodenal atresia and swelling was observed in some embryos (Fig. 7B) , as already reported . E18.5 Fgf10−/− embryos were divided into three classes: no duodenal atresia, incomplete atresia (Type I) and complete atresia (Type II). Although embryos with no atresia also had pronounced duodenal defects, including a decrease in villus length and villus differentiation defects, only type I and type II embryos were analyzed in detail in the following.
Villus formation is normally initiated shortly before E14.5 by the formation of epithelial elevations. In Fgf10−/− embryos this process was delayed, as protrusions were either lacking or subnumerary compared to wildtype ( Fig. 7C-D) . This reflected in a lack of villi in the anterior-most duodenum and stunted villi in the mid duodenum at E18.5; a phenotype that was more pronounced in type II atresia ( Fig. 7I-K) . The posterior duodenum appeared unaffected by the loss of Fgf10 (data not shown).
Changes in the proliferative and apoptotic indices do not suffice to account for epithelial hypoplasia
The observed hypoplasia of the duodenum could be due to decreased proliferation, increased apoptosis or loss of progenitor cells through premature or excessive differentiation. No difference in proliferative activity was seen in the epithelium at E14.5 ( Fig. 7C-G) , and contrarily to what has been observed in other organs, loss of Fgf10 led to a relative increase in proliferating cells per epithelial area at E18.5 ( Fig. 7H and L-Q) . The proliferating cells were located in the basal position of progenitor cells, and their absolute number was unchanged. The relative increase in cell proliferation could thus be ascribed to loss of villus epithelium. A TUNEL analysis demonstrated increased cell death at E18.5 ( Fig. 7R-T) , but not at E14.5 (results not shown). Strikingly, the majority of the apoptotic cells had been shed from the villus into the lumen, a process thought to occur by anoikis. Cell shedding is normally not observed in the embryonic duodenum, as it constitutes the departure of mature enterocytes from the constantly regenerating adult epithelium. The presence of shed cells in the embryonic duodenum could therefore indicate a maturation defect. As the changes in proliferation and apoptosis were furthermore insufficient to account for the observed hypoplasia we next proceeded to analyze differentiation.
Fgf10 is necessary for suppression of premature differentiation
Enteric differentiation normally starts at E16.5. However, when analyzing cell differentiation in E14.5 Fgf10−/− duodenum several ChrgA + endocrine cells (Fig. 8A, D) , Cryptdin3 + Paneth cells (Fig. 8F) and Fabp2 + absorptive enterocytes (Fig. 8H) , and an increased number of Tff3 + cells (Fig. 8J) were found, signifying that loss of Fgf10 results in premature differentiation of all enteric cell lineages. Surprisingly, many Tff3 + pre-goblet cells (Fig. 8I) were found in the WT duodenum already at E14.5, indicating that this cell lineage starts forming earlier than was previously thought.
We expected to see a loss of differentiated cells at E18.5 similarly to what has been observed in the pancreas (Bhushan et al., 2001) as a consequence of the overall loss of progenitor cells to premature differentiation. Attesting to the great regenerating potential of the intestinal epithelium, most enteric cell types were however present at proportionally normal levels when analyzed at E18.5 ( Supplementary  Fig. S5) , with exception of enterocytes (Fabp2 + ) and enterochromaffin cells (secretin + ), which were greatly decreased.
In order to determine if the observed premature cell differentiation was associated with a decrease in factors needed for stem cell and/or progenitor maintenance, we analyzed for changes in BMI1, nuclear beta-catenin and HES1. In agreement with our results from the gainof-function model, we did not observe any changes in HES1 ( Supplementary Fig. S5 ). BMI1 is widely expressed in the nuclei of embryonic cells at E14.5 ( Fig. 9A and C) . In the absence of FGF10 we did however observe patches of BMI1 negative cells located on epithelial ridges ( Fig. 9B and D) . These BMI1 negative cells also did not express beta-catenin in the nucleus, when analyzed with an antibody that can detect both nuclear and membrane bound beta-catenin ( Fig. 9E-F) .
We conclude that the epithelial hypoplasia observed in the duodenum of Fgf10−/− embryos is primarily the effect of loss of progenitor cells by premature differentiation at E14.5.
Discussion
The intestinal epithelium is an excellent model for studies of the transition from progenitor maintenance to cell differentiation, as it allows us to study this transition in both time and space. During embryogenesis, the intestinal epithelium goes through a temporal transition from a uniform epithelium consisting exclusively of progenitor cells to an epithelium consisting of both progenitors and differentiated cells. Furthermore, a spatial transition also takes place, as the crypt-villus unit is established with stem cells and progenitor cells located in the basal region and differentiated cells located primarily on the villus (see Fig. 10 ). This study provides evidence that mesenchymal secretion of FGF10 is necessary for stem and progenitor cell maintenance in the duodenum through suppression of premature differentiation, leading to severe defects in loss and gain-of-function models.
FGF10 is expressed by the mesenchyme at high levels at E14.5 and decreases hereafter, but is still present before birth, while FGFR2b is expressed in basally located epithelial cells. This expression pattern makes the ligand-receptor pair a likely candidate for regulation of enteric progenitor cells both before and after establishment of the crypt-villus unit. Previous studies based on loss-of-function models have shown that FGF10 and/or FGFR2b signaling is necessary for expansion and survival of the enteric progenitor population Sala et al., 2006) , while studies of gain-of-function models in other endodermal organs have suggested that FGF10 primarily is required for maintenance of the progenitor population through inhibition of differentiation (Hart et al., 2003; Norgaard et al., 2003; Nyeng et al., 2007) . In this study we therefore undertook to compare gain-of-function and loss-of-function of Fgf10 in the duodenum. Using a pPdx1-Fgf10 FLAG construct we ectopically overexpressed Fgf10 in the duodenal epithelium, in order to abolish the normal FGF10 gradient. Fgf10 FLAG mRNA expression was mosaic at E12.5 and confined to the crypt areas at E18.5. Similar to endogenous mesenchymal FGF10, the transgenic FGF10 protein was secreted and could therefore be found throughout the epithelium at E18.5. This secretion made Fgf10 FLAG available to the entire duodenal epithelium, and effects of the transgene were seen throughout the radial axis. The pPdx1-Fgf10 FLAG model thus likely involves both autocrine signaling in the FGF10 FLAG and FGFR2b expressing epithelial cells and paracrine signaling from the aforementioned cells to neighboring epithelial and mesenchymal cells. Co-expression of FGF-receptor and ligand leading to autocrine FGF-signaling is not as unusual as one could assume, and has been observed in for example muscle cells (Miyamoto et al., 1998) , embryonic stem cells (Dvorak et al., 2005) and many cancers (Powers et al., 2000) , and we therefore find it likely that autocrine signaling is also taking place in the pPdx1-Fgf10 FLAG model. Although the mesenchyme does not express FGFR2b, it expresses low levels of the FGFR2c isoform, which also binds FGF10, although with a significantly lower specificity compared to FGFR2b (Zhang et al., 2006) ). We therefore cannot exclude that some effects are mediated through the mesenchyme.
At E18.5, the duodenal epithelium is in the process of forming crypt-villus units, and radial patterning has already led to a niche specific localization of progenitor and stem cells. Ectopic overexpression of Fgf10 causes a disruption of the polarization of the crypt-villus axis due to expansion of the progenitor/stem cell niche, with expression of basal markers PDX1, FGFR2, Cdx2 and Shh expanded along the entire villus axis. The stem cell marker BMI1 is confined to a few cells located at position +4 near the bottom of adult crypts (Sangiorgi and Capecchi, 2008) . We here show that BMI1 is also confined to a small cell population in the forming crypt at E18.5, but is expanded throughout the entire epithelium in the pPdx1-Fgf10 FLAG model.
Also, dividing cells were distributed throughout the villus, while overall apoptotic and proliferative indices were unchanged. These data demonstrate that FGF10 overexpression outside the basal domain is sufficient to expand the basal niche and disrupt radial patterning, which strongly suggests that FGF10 secreted from the mesenchyme normally creates a gradient for radial patterning of intrinsic endodermal factors such as Cdx2 and Shh. The fact that the expansion of the basal niche did not lead to an increase in the number of proliferating cells furthermore demonstrates that FGF10 maintains cells in a non-dividing state, resembling enteric stem cells rather than the frequently dividing progenitor cells. Upregulation of the stem cell marker Bmi1 in all epithelial cells strongly supports this notion.
As the expansion of the basal niche was not caused by an increase in the proliferative index or changes in cell survival, we next proceeded to analyze cell differentiation. Our analysis showed that overall differentiation was attenuated, although not completely inhibited by the presence of FGF10. Paneth cells were completely absent, while differentiation of endocrine cells and absorptive enterocytes was markedly attenuated, and goblet cell maturation arrested at an immature stage. Current models support an early divergence of a common secretory precursor cell from the enterocyte precursor and a subsequent divergence into a Paneth/goblet precursor and an endocrine precursor. Since FGF10 has an inhibitory effect on enterocyte differentiation, as well as on secretory cell fates, it is either affecting the common precursor, or affecting both the enterocyte precursor and specific secretory precursor cell stages. The B-class bHLH transcription factor Math1 is required for intestinal secretory cell differentiation (Yang et al., 2001) , and is upstream from the zinc finger transcription factor GFI1, which has been shown to affect the choice between a Paneth/goblet fate and an endocrine fate (Shroyer et al., 2005) . We see a marked decrease in both Math1 + and GFI1 + cells, demonstrating that very few secretory precursor cells form. We therefore conclude that FGF10 suppress differentiation already at the multipotent stem/progenitor cell stage. Interestingly, the few secretory cells that do bypass the FGF10 inhibitory effect preferentially enter the goblet cell lineage. Immature goblet cells still have potential for mitosis (Karam, 1999; Troughton and Trier, 1969) , while Paneth and enteroendocrine cells are non-proliferative. Consequently, the presence of goblet cells may be due to its unique capacity for expansion in the differentiating state, allowing the few cells that escape initial repression to expand.
Investigating putative downstream mechanisms of FGF10 signaling, we find that Fgf10 overexpression leads to upregulation of FGFRsignaling targets Sprouty2, Etv4 and Etv5. Sprouty2 is a feedback inhibitor of FGFR-signaling that exerts its inhibitory effect on RTKsignaling by intercepting elements of the MAP-kinase pathway (Tefft et al., 2002) , while ETV4 and ETV5 are transcription factors that mediate FGFR effects downstream of MAP-kinase signaling on target genes in the lung and pancreas Liu et al., 2003) . Based on these results we conclude that the MAP-kinase pathway is activated by FGF10 in the intestine. The observed upregulation of Etv4 and Etv5 is particularly interesting, as the Ets factor transcription family has been implicated in both enteric development and disease. Several Ets factors are expressed in the intestinal epithelium during development (Jedlicka and Gutierrez-Hartmann, 2008) , but so far only Elf3 (E74-like factor-3) KO mice have been shown to have an intestinal phenotype. These mice have impaired villus morphogenesis and enterocyte differentiation (Ng et al., 2002) with some similarity to what we have observed in the FGF10 KO model. The epithelial Ets factors do not seem to have completely overlapping functions in the intestines, as a dominant negative approach targeting all Ets factors in the intestinal epithelium, resulted in a somewhat different phenotype (Jedlicka et al., 2009) . Etv4 KO mice are viable and only have known defects in male sexual function and neuronal development (Laing et al., 2000) , and Etv5 KO mice only have known defects in spermatogonial differentiation (Chen et al., 2005) . Etv4 and Etv5 are both members of the PEA3 subfamily and their shared expression domain indicates possible redundancy; it will therefore be interesting to know the intestinal phenotype of the compound Etv4 and Etv5 KO, although the early lethality of this mutant (Zhang et al., 2009 ) makes the analysis dependent on a tissue targeted approach. Ongoing research is currently addressing the roles of ETV4 and ETV5 in more detail.
Hedgehog, Wnt, BMP and Notch signaling also regulate intestinal morphogenesis, and the pathways interact with each other to balance progenitor maintenance and differentiation. We show that Fgf10 overexpression in the duodenum interferes with Sonic Hedgehog, but we did not find evidence to suggest changes in WNT, BMP or Notchsignaling. Shh was upregulated and basal confinement of Shh disrupted, but based on our study it is not possible to conclude whether this is a direct effect, or a secondary effect due to expansion of the progenitor cells. Since Etv4 and Etv5 have been shown to regulate Shh downstream of FGF-signaling in the limb bud (Zhang et al., 2009) , it is likely that this direct mechanism is also active during radial patterning of the intestinal epithelium.
Given that gain-of-function of Fgf10 resulted in a spatial expansion of the stem cell and progenitor niche due to attenuation of cell differentiation, we questioned using a loss-of-function model whether Fgf10 is required for the temporal maintenance of progenitor cells before terminal differentiation, i.e. when FGF10 levels are high, and found that this is indeed the case. Fgf10 loss led to premature differentiation of all enteric cell lineages as early as E14.5. Whereas premature differentiation of all enteric cell lineages has not previously been observed, premature differentiation of Paneth cells are also seen in Hes1 KO (Suzuki et al., 2005) and Lgr5 KO mice (Garcia et al., 2009 ). Furthermore, differentiation of Paneth cells and enterocytes has been observed in the progenitor niche of adult enteric cells expressing a constitutively active Rac1 (Stappenbeck and Gordon, 2000) . Our observation that loss of FGF10 leads to premature differentiation of all enteric cell lineages as early as E14.5, thus makes it likely that the FGF10 gradient provides the position dependent cue for cellular differentiation (see Fig. 10 ), upstream from intracellular signaling pathways in the epithelial cell lineages. Whereas we were unable to analyze changes in Lgr5 and Rac1 in this study, we did see a loss of the Wnt signaling target and stem cell marker BMI1 in some epithelial cells at E14.5. These cells also lacked nuclear beta-catenin. We did not observe any changes in HES1 expression in the duodenum after FGF10 loss, although we have previously shown HES1 to be affected by changes in FGF10 levels in the pancreas and stomach.
In accordance with previous studies in the colon and cecum we observed hypotrophy of the duodenal epithelium during later stages, as evidenced by a decreased epithelial area and incomplete maturation with a low number of stunted villi, but in contrast with their findings we did not see any changes in cell proliferation at E14.5, when the Fig. 10 . Model of progenitor cell maintenance in the duodenum. The immature duodenal epithelium at E12.5 (left side of figure) consists of undifferentiated multipotent progenitor cells. At this time, FGF10 is secreted from the mesenchyme at a high level which probably is sufficient to reach all the epithelial cells. The progenitor cells all express the FGF10 receptor FGFR2b and are dependent on mesenchymal FGF10 in order not to differentiate prematurely. At E18.5 (right side of figure) , the duodenum has formed crypt-villus units with stem cells and progenitor cells located in the crypt region and differentiated cells located primarily on the villus. The progenitor cells still express FGFR2b, while differentiated cells cease to express the receptor. At this time, FGF10 is secreted at lower levels from basally located mesenchymal cells. This results in a gradient of FGF10 with highest expression in the crypt area. Maintenance of this gradient is necessary in order to restrict the progenitor niche and maintain radial patterning of essential signaling factors such as Cdx2 and Shh. The drawings are graphical representations of H&E stained E12.5 and E18.5 duodenal sections. hypotrophy was already starting to manifest, and actually observed a relative increase in cell proliferation at E18.5. This relative increase can however be ascribed to a decrease in villus epithelium, as proliferating cells are found only in the basal epithelium. With regard to cell survival, which aforementioned studies also found affected in the absence of Fgf10, we did observe an increase in apoptosis, but not until E18.5, and only in the form of cell shedding, which has so far only been reported as apoptosis of mature cells. We therefore conclude that the stunted duodenal morphogenetic development and possibly also the duodenal atresia observed in Fgf10−/− mice is a result of epithelial reduction caused by a loss of progenitor cells due to premature differentiation. We speculate that these premature cells subsequently undergo apoptosis and are shed from the epithelium.
After analyzing the effect of loss and gain of Fgf10, we have demonstrated that enteric stem cells and progenitor cells in the early embryonic epithelium are dependent on a mesenchymal signal in the form of FGF10 in order not to differentiate prematurely, and that a morphogen gradient of Fgf10 with highest expression in the crypt area is necessary in order to restrict the progenitor niche during later development (see Fig. 10 ). Prior to birth, the levels of FGF10 are negligible, while FGF1 is upregulated, suggesting that this FGFR2b agonist takes over the function of FGF10 postnatally. We conclude that FGF10 is necessary for maintenance of the embryonic enteric progenitor cell population and ectopic FGF10 overexpression is sufficient to prevent cell differentiation in the context of the otherwise normal intestine. This underlying role of Fgf10 has not previously been revealed in the intestines. This emphasizes the need to inspect all aspects of development and use several different models in order to fully comprehend the function of a signaling molecule. We demonstrate that FGF10 signals through the MAPK pathway and induces BMI1, ETV4 and ETV5 in the duodenum. This result is very interesting in the light of the upregulation of Fgf10, Fgfr2b (La Rosa et al., 2001; Matsuike et al., 2001) , Bmi1 (Kim et al., 2004) and ETV4 (Jedlicka and Gutierrez-Hartmann, 2008) observed in colorectal cancers, pointing to a role of this pathway in both embryogenesis and carcinogenesis.
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